HUTCHMED Sets 30 July Board Meeting to Approve 2026 Interim Results; Webcast Details Announced

Bulletin Express06-30 16:44

HUTCHMED (China) Limited has scheduled its board meeting for 30 July 2026 to approve and publish interim results for the six months ended 30 June 2026. The announcement will be released at 7:00 p.m. Hong Kong Time on the same day.

Management will host two live webcasts to discuss the results: an English session with Q&A at 8:00 p.m. on 30 July 2026 and a Putonghua session at 8:30 a.m. on 31 July 2026. Both events can be accessed through the company’s website (www.hutch-med.com/event/), where presentation materials will be available for download shortly before the broadcasts, and replays will be posted afterward.

The board is chaired by Non-executive Director Dr Dan Eldar. Executive leadership includes Chief Executive Officer and Chief Scientific Officer Dr Weiguo Su and Acting Chief Executive Officer and Chief Financial Officer Johnny Cheng Chig Fung. The company secretary is Non-executive Director Edith Shih.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment